ABCG2 and non-small cell lung carcinoma: The meta-analysis results showthat the polymorphism ABCG2 421C>A had no relationship with outcomes ofchemotherapy for NSCLC (P > 0.05), and ABCG2 34G>A wassignificantly correlated with skin toxicity (P < 0.05)(FiguresS1-S8).